Symbicort Rapihaler 200/6 is a medicine containing the active ingredient(s) budesonide + formoterol (eformoterol). On this page you will find out more about Symbicort Rapihaler 200/6, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: budesonide + formoterol (eformoterol)
Information for medicine and pack size:
Symbicort Rapihaler 200/6 pressurised inhalation, 120 actuations
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
ASTHMA: Symbicort Rapihaler is indicated for the treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate in adults and adolescents. This includes: patients who are symptomatic on inhaled corticosteroid therapy; patients who are established on regular long-acting beta2-agonist and inhaled corticosteroid therapy. There are two alternative treatment regimens: - Symbicort maintenance and reliever therapy - Symbicort maintenance therapy The 100/6 and 200/6 strengths should not be used for the Symbicort maintenance and reliever therapy regimen. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): Symbicort is indicated for the symptomatic treatment of moderate to severe COPD (FEV1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. Symbicort is not indicated for the initiation of bronchodilator therapy in COPD.
Table of characteristics
|Visual appearance||Contents in metal can with plastic valve & actuation counter. After evaporation of the propellant the residue is free from visible contaminants. The external & internal can & valve surfaces are free from corrosion and significant defects.|
|Dosage Form||Inhalation, pressurised|
|Route of administration||Inhalation|
120 doses: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Type||Inhaler - Metered Dose|
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||2 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 April 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Symbicort Rapihaler 50/3 Metered dose inhaler - myDr.com.au
Symbicort Rapihaler 50/3 Metered dose inhaler - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Asthma Emergency - An Asthma Australia site
Any person with asthma can have a flare-up or worsening of asthma symptoms at any time. A sudden or severe flare-up is often called an asthma attack.
Read more on Asthma Australia website
Found 0 results